Iconocast Logo

Welcome To Iconocast

How to add a URL link from your web site to the Iconocast web sites

Virtual tour of Southern California



 

Recent News and Articles on the Keywords: thyroid tumor + thyroid tumors + thyroid  Related to the article below (Last Update: 8/5/2008)

Thyroid check is wise move for elders
The Star-Ledger - NJ.com, NJ -
On occasion, a benign tumor or, more rarely, a malignant tumor of the thyroid gland produces abnormal levels of thyroid hormone. Because the thyroid is ...
OXiGENE Reports Second Quarter 2008 Results
FOXBusiness -
In clinical studies in solid tumors, ZYBRESTAT has demonstrated potent and selective activity against tumor vasculature, as well as clinical activity ...
OXiGENE Reports Second Quarter 2008 Results MarketWatch
all 8 news articles »  OXGN - OTC:CMTX
OxiGene, Inc. Q2 2008 Earnings Call Transcript
Seeking Alpha, NY -
Based on the overall clinical results achieved today with Zybrestat and ATC, and thyroid cancer, we continue to be very optimistic about the prospects for ...OXGN
Health calendar
Asheville Citizen-Times, NC -
THYROID DISFUNCTION: Learn how to heal the thyroid, 6:30 pm Aug. 12, Earth Fare South, 1856 Hendersonville road, Asheville. Free; pre-registration required. ...
Early screening is crucial to improving recovery rates for breast ...
Orlando Sentinel, FL - 16 minutes ago
When searching through a family tree for breast cancer, look for family histories of ovarian cancer, thyroid cancer and uterine cancer, which are related to ...
Exelixis starts thyroid cancer treatment test
Bizjournals.com, NC - Jul 21, 2008
Exelixis Inc. started a late-stage clinical trial of a treatment for medullary thyroid cancer. The South San Francisco company (NASDAQ: EXEL) will test the ...
Exelixis shares rise as late-stage study begins Forbes
Exelixis commences late-stage trial of XL184 to treat medullary ... RTT News
all 23 news articles »  EXEL
On a 'Re-Mission' to save lives of kids with cancer
USA Today - Aug 3, 2008
Wilkins, of Norfolk, says she stopped taking daily thyroid medications ? required because radiation damaged her thyroid ? because she felt better. ...
Exelixis Initiates Phase 3 Trial of XL184 in Medullary Thyroid Cancer
FierceBiotech, DC - Jul 23, 2008
Activating mutations in RET are also present in the tumor DNA of up to 50% of sporadic MTC patients with no familial history of thyroid cancer. ...EXEL
Exelixis: Pivotal Study Raises Hopes for Potential Thyroid Cancer Drug
RedOrbit, TX - Jul 22, 2008
While thyroid cancer in general is one of the least deadly tumor types, medullary subtypes are particularly difficult to treat, given their aggressive ...EXEL
Exelixis Initiates Phase 3 Trial of XL184 in Medullary Thyroid Cancer
ADMET.net (press release), UK - Jul 24, 2008
Exelixis, Inc. has announced that the phase 3 registration trial of XL184 as a potential treatment for medullary thyroid cancer (MTC) has been initiated. ...EXEL
Source: Google News

Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. -
EL Mazzaferri, SM Jhiang - Am J Med, 1994 - ncbi.nlm.nih.gov
... 12 months; (2) reduced by female sex, surgery more extensive than lobectomy, and
131I plus thyroid hormone therapy; and (3) unaffected by tumor histologic type ...

… expression of galectin-1 and galectin-3 in thyroid tumors. Potential diagnostic implications -
XC Xu, AK el-Naggar, R Lotan - American Journal of Pathology, 1995 - ASIP
... Pathology. REGULAR ARTICLES. Differential expression of galectin-1 and
galectin-3 in thyroid tumors. Potential diagnostic implications. XC ...

Somatic deletions and mutations in the Cowden disease gene, PTEN, in sporadic thyroid tumors -
PL Dahia - Cancer Research, 1997 - AACR
... with Three Bone Morphogenetic Protein-related Genes, May Encode Novel Tumor Suppressors
Down-Regulated in Sporadic Follicular Thyroid Carcinogenesis Cancer Res ...

BRAF Mutation in Papillary Thyroid Carcinoma -
Y Cohen, M Xing, E Mambo, Z Guo, G Wu, B Trink, U … - jnci, 2003 - jnci.oxfordjournals.org
... Thus, activation at various points in the RAS/RAF/MEK/MAPK pathway is a key event
in the most common type of malignant thyroid tumor. ... 5 Gimm O. Thyroid cancer. ...

BRAF Mutations in Thyroid Tumors Are Restricted to Papillary Carcinomas and Anaplastic or Poorly … -
MN Nikiforova, ET Kimura, M Gandhi, PW Biddinger, … - Journal of Clinical Endocrinology & Metabolism, 2003 - Endocrine Soc
... and poorly differentiated carci- nomas were further reviewed to determine the presence
of areas of a pre-existing well-differentiated thyroid tumor (Ta- ble 2 ...

High Prevalence of BRAF Mutations in Thyroid Cancer Genetic Evidence for Constitutive Activation of … -
ET Kimura, MN Nikiforova, Z Zhu, JA Knauf, YE … - Cancer Research, 2003 - AACR
... PTCs 3 are the most common thyroid malignant tumor. ... We found no mutations in exon
11 of BRAF in any of the 128 thyroid tumor samples or in the cell lines. ...

Natural history, treatment, and course of papillary thyroid carcinoma -
LJ DeGroot - Journal of Clinical Endocrinology & Metabolism, 1990 - Endocrine Soc
... and JA Ridge Tumor Above the Spinal Accessory Nerve in Papillary Thyroid Cancer
That Involves Lateral Neck Nodes: A Common Occurrence Arch Otolaryngol Head ...

Expression of Angiogenesis Stimulators and Inhibitors in Human Thyroid Tumors and Correlation with … -
G Bunone, P Vigneri, L Mariani, S Buto, P Collini, … - American Journal of Pathology, 1999 - ASIP
... To assess the potential role of angiogenesis factors in human thyroid tumor growth
and spread, we analyzed their expression by semiquantitative RT-PCR and ...

PAX8-PPARgamma 1 Fusion in Oncogene Human Thyroid Carcinoma -
TG Kroll, P Sarraf, L Pecciarini, CJ Chen, E … - Science's STKE, 2000 - stke.sciencemag.org
... revealed strong, diffuse nuclear expression of PAX8-PPAR 1 in paraffin-embedded
thyroid tumor sections in seven of the eight thyroid follicular carcinomas (Fig ...

High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas. -
JA Fagin, K Matsuo, A Karmakar, DL Chen, SH Tang, … - Journal of Clinical Investigation, 1993 - pubmedcentral.nih.gov
... not known. We examined normal, benign, and malignant thyroid tissue for
structural abnormalities of the p53 tumor suppressor gene. ...

Source: Google Scholar
 

Thyroid Nodules (tumors)


The thyroid gland is located in the front of the neck at the level of the collarbone. It produces hormones that regulate the body's metabolism, bone growth, and heat production. Thyroid nodules are also called thyroid tumors.

Benign Thyroid Nodules

More than 95% of thyroid nodules are benign (non-cancerous), but tests are needed to determine if a nodule is cancerous. Benign nodules include:

  • Multinodular goiter, also called non-toxic goiter. The word goiter means the thyroid gland has grown too large. This usually happens when the pituitary gland (in the brain) creates too much thyroid stimulating hormone (TSH).

Article continues below and (thank you)

 

If the goiter is small, the problem may be treated with thyroid hormone pills. Surgery is needed if the goiter is large or does not stop growing after taking thyroid hormones. A large thyroid gland can press against the trachea (windpipe) or esophagus (food tube) and cause difficult breathing or eating.
  • Chronic thyroiditis (Hashimoto's disease) is an inflammation of the thyroid gland that develops slowly. It frequently leads to a decreased function of the thyroid (hypothyroidism). Middle-aged women are most commonly affected.

    Thyroditis occurs when the body's own immune system destroys the cells in the thyroid gland. Chronic thyroiditis is most common in women and people with a family history of thyroid disease.

  • Benign follicular adenomas. The word follicular means the cells look like a group of small circles under a microscope. If the follicular cells are contained within the nodule, the condition is called benign. If the cells have invaded the surrounding tissue, the diagnosis is cancer. The nodule must be surgically removed and examined under a microscope to look for evidence of invasion into the normal thyroid tissue or blood vessels.
  • Thyroid cysts are nodules filled with fluid. They can be small or large and might appear suddenly. If a nodule has both fluid and solid parts, it is called a complex nodule. They need to be surgically removed if they cause neck pain or difficultly swallowing.
A biopsy is needed to determine if a nodule is benign or cancerous. Your doctor may just watch a benign nodule to see if it grows larger or causes symptoms. If it grows larger, you might need another biopsy. Thyroid hormones can suppress the activity of the gland so that it does not develop more nodules.

Thyroid Cancer

Every year 20,000 new cases of thyroid cancer are diagnosed in the United States. Women are three times more likely to have thyroid cancer than men. Thyroid cancer is most common after 30, but it can develop at any age.

There are four types of thyroid cancer tumors:

Papillary tumors

  • They account for 78% of thyroid cancers.
  • Papillary tumors often spread to lymph glands in the neck (metastasis), but rarely spread to distant organs.
  • The lungs and bones are the most common sites of metastasis.
  • Papillary tumors develop more often during 30-60 years of age.
  • They occur three times more often in women than in men.
  • The cure rate is 97% or better if treated correctly.
  • Ten years after treatment, approximately 80%-90% of patients are still living.
Follicular (Hurthle cell) tumors

  • The second most common thyroid cancer.
  • Metastasis to distant organs, (lungs, bones, brain, liver, bladder, skin) is common.
  • Metastasis to the lymph glands is less common than in papillary tumors.
  • Follicular tumors usually develop during 40-60 years of age.
  • They occur three times more often in women than men.
  • The cure rate is 97% or better if treated correctly.
Medullary tumors

  • Metastasis to the lymph nodes occurs in the early stage of the tumor.
  • After surgery, the hormone calcitoin is measured every four to six months to check for recurrence of the disease.
  • The survival rate is 90% if the disease has not spread outside of the thyroid gland. Survival is 70% if disease has spread to lymph glands in the neck, and 20% if the disease has spread to distant organs.

Anaplastic cancers

  • The least common type of thyroid cancer, but the most dangerous.
  • Three years after diagnosis and treatment, only 10% of patients are alive.
  • More than 90% of anaplastic cancers spread to the lymph glands in the neck and distant organs.
  • The tumors grow rapidly.
  • The average age of onset is 65 years of age and older.
  • Men are two times more likely than women to have anaplastic cancer.
  • Many patients require a tracheostomy (breathing tube placed into the neck) because the tumor presses against the trachea and inhibits breathing.
  • This cancer must be detected early.
  • The cure rate is very low.

Symptoms

Most thyroid nodules cause no symptoms, but sometimes the person or a family member might see or feel a lump in the front of the neck.

The lump may cause pain or difficulty swallowing.

If the nodule is creating an excessive amount of thyroid hormone, the person might feel heat intolerance, palpitations, fast heart beat, nervousness, insomnia, increased bowel movements, absent periods, fatigue, weight loss, hair loss or muscle weakness.

Causes and Risk Factors

The exact reason nodules grow in the thyroid gland is not known. But these factors increase the risk:

  • Heredity. If a parent or sibling had a thyroid nodule, the chance of developing a nodule is increased.
  • Age. The risk of developing a nodule increases as you age.
  • Gender. Woman develop nodules more often than men
  • Thyroiditis. Nodules are more likely to form in people who have chronic inflammation of the thyroid gland.
  • Radiation exposure to the head or neck. Babies, children, and teenagers were treated with radiation for acne or enlarged tonsils in the 1940s and 1950s. People who had these treatments have an increased risk.

    Exposure to nuclear power plant accidents, or radioactive particles released into the air during atomic weapons testing also increases the risk.
Diagnosis

A combination of symptoms, medical history, physical exams, and tests are used to determine a diagnosis. Thyroid nodules are often found during a routine physical examination. Your doctor might feel an abnormal lump on the front of your neck.

  • The TSH blood test measures a pituitary gland hormone that stimulates the thyroid gland. If the TSH level is increased, the thyroid gland may not be functioning properly. Additional blood tests are needed to measure other thyroid hormones. Both pituitary and thyroid tests are required to confirm that the problem is located in the thyroid gland.
  • T4 by RIA, T3 by RIA, and Thyroid Binding Globulin are blood tests used to measure the other thyroid hormones.
  • A thyroid scan measures the amount of iodine the thyroid can absorb.
  • Fine Needle Aspiration Biopsy (FNA). A needle is placed into the thyroid nodule, the cells are aspirated, and then examined under a microscope to determine if a nodule is cancerous.
  • Thyroid ultrasound uses painless sound waves to create an image of the thyroid gland and identify nodules. Ultrasound can show if a nodule is solid or a fluid-filled cyst, but it cannot determine if a nodule is benign or malignant.
Treatments

Thyroid tumors require surgical removal of part or all of the thyroid gland (thyroidectomy). The surgeons at the Head and Neck Cancer Center are experts in the treatment of thyroid tumors.

Radioactive Iodine treatments are given to most patients with thyroid cancer after the tumor is removed.

 
 
 
Google
Web www.iconocast.com
 
 
Continue News With: News9A ; ALL THE NEWS : News1 ; News2 ; News3 ; News4 ; News5 ; News6 ; News7 ; News8 ; News9 ; News9A


ADVERTISEMENT

Iconocast is about learning and teaching without borders; we offer eMarketing, Internet Advertising, Internet Marketing, Search Engine Optimization, Search Engine Marketing, Online Branding, and eMarketing News Services.

 

Iconocast Home Page

 © 2002-2006

Keywords:

Contact Iconocast